HER2/EGFR in Cancer Research

This cluster of papers focuses on the use of HER2-targeted therapies, such as trastuzumab and pertuzumab, in the treatment of HER2-positive breast cancer. It explores the mechanisms of action, resistance, and combination therapies involving chemotherapy and monoclonal antibodies. The cluster also delves into the role of EGFR, neuregulin 1, and ADAM metalloproteinases in HER2 signaling and breast cancer progression.

Journals publishing in this area

1

Journal of Clinical Oncology

Journal of Clinical Oncology

ISSN 0732-183X5,893 articles in this topic

733h-index

1.70Impact

166.4KArticles

4.4MCitations

2

Cancer Research

ISSN 0008-54725,623 articles in this topic

465h-index

0.54Impact

151.6KArticles

2.1MCitations

3

Annals of Oncology

ISSN 0923-75343,390 articles in this topic

384h-index

1.10Impact

67.1KArticles

1.1MCitations

4

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment

ISSN 0167-68061,755 articles in this topic

219h-index

2.71Impact

12.4KArticles

504.1KCitations

5

Clinical Cancer Research

ISSN 1078-04321,704 articles in this topic

417h-index

1.39Impact

27.3KArticles

1.6MCitations

6

European Journal of Cancer

ISSN 0959-80491,596 articles in this topic

295h-index

2.05Impact

41.9KArticles

833KCitations

7

British Journal of Cancer

ISSN 0007-0920888 articles in this topic

344h-index

5.57Impact

28.5KArticles

1.5MCitations

8

The Lancet Oncology

ISSN 1470-2045409 articles in this topic

511h-index

9.26Impact

12KArticles

1MCitations

9

International Journal of Orthopaedics and Rheumatology

ISSN 2664-96911 articles in this topic

1h-index

0.03Impact

47Articles

2Citations